CN103110745B - Medicine for treating impetigo - Google Patents
Medicine for treating impetigo Download PDFInfo
- Publication number
- CN103110745B CN103110745B CN201210530670.5A CN201210530670A CN103110745B CN 103110745 B CN103110745 B CN 103110745B CN 201210530670 A CN201210530670 A CN 201210530670A CN 103110745 B CN103110745 B CN 103110745B
- Authority
- CN
- China
- Prior art keywords
- medicine
- flos
- radix
- raw material
- cortex phellodendri
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a medicine for treating impetigo. The medicine comprises the following raw material ingredients by weight ratio: 28-32 of leguminosae, 28-32 of cortex phellodendri chinensis, 8-12 of aluminis usti, 18-22 of capsicum annuum seed, 3-7 of borneol, 8-12 of coptis chinensis franch, 4-8 of flos celosiae cristatae, 6-10 of radix notoginseng, 2-6 of papaver rhoeas, 1-5 of camellia japomica, 6-10 of senecio scandens, 4-8 of radix sophorae tonkinensis, 5-7 of fructus mume, 1-5 of calcium oxide and 1-5 of microcos paniculata linn. The recipe takes traditional Chinese medicines capable of clearing heat, toxic materials and dampness as main ingredients; and the medicine has a good curative effect on treating impetigo, is low in cost and does not have toxic or side effect.
Description
Technical field:
The present invention relates generally to the field of Chinese medicines, particularly relates to a kind of medicine for the treatment of pustule ulcer.
Background technology:
Impetigo is a kind of common acute festering type dermatosis, is commonly called as " impetigo ".There is the characteristic of contagion and self inoculation infection, easily popular in child.Pathogen is mainly the staphylococcus aureus of coagulase positive or beta hemolytic streptococcus is independent or mixed infection.Summer, high, the high humidity of solar term temperature in autumn, skin maceration etc., all easily making pathogenic bacteria invade skin breeding, creating favorable conditions for inspiring primary disease.At present, the medicine for the treatment of impetigo is more both at home and abroad, but it is high to there is price, the defect of DeGrain.
Summary of the invention:
The object of the invention is exactly the defect in order to make up prior art, provides one to treat low, the eutherapeutic medicine of pustule ulcer expense.
The present invention is achieved by the following technical solutions:
Treat a medicine for pustule ulcer, it is characterized in that: the weight proportion of its each raw material components is: Radix Astragali 28-32, Cortex Phellodendri 28-32, dried Alumen 8-12, chilli seed 18-22, Borneolum Syntheticum 3-7, Rhizoma Coptidis 8-12, Flos Celosiae Cristatae 4-8, Radix Notoginseng 6-10, Flos Papaveris rhoeadis 2-6, Flos Camelliae Japonicae 1-5, Herba Senecionis Scandentis 6-10, Radix Sophorae Tonkinensis 4-8, Fructus Mume 5-7, quicklime 1-5, Folium Microcoris paniculatae 1-5.
Treat a medicine for pustule ulcer, it is characterized in that: the weight proportion of its each raw material components is: the Radix Astragali 30, Cortex Phellodendri 30, dried Alumen 10, chilli seed 20, Borneolum Syntheticum 5, Rhizoma Coptidis 10, Flos Celosiae Cristatae 6, Radix Notoginseng 8, Flos Papaveris rhoeadis 4, Flos Camelliae Japonicae 3, Herba Senecionis Scandentis 8, Radix Sophorae Tonkinensis 6, Fructus Mume 6, quicklime 3, Folium Microcoris paniculatae 3.
Advantage of the present invention is:
Formula of the present invention reuses the Chinese medicine of heat-clearing and toxic substances removing, heat clearing and damp drying, energy Quick itch stopping, and have good curative effect for treatment pustule ulcer, cost is low, has no side effect.
Detailed description of the invention:
Treat a medicine for pustule ulcer, the weight (g) of its each raw material components is: the Radix Astragali 30, Cortex Phellodendri 30, dried Alumen 10, chilli seed 20, Borneolum Syntheticum 5, Rhizoma Coptidis 10, Flos Celosiae Cristatae 6, Radix Notoginseng 8, Flos Papaveris rhoeadis 4, Flos Camelliae Japonicae 3, Herba Senecionis Scandentis 8, Radix Sophorae Tonkinensis 6, Fructus Mume 6, quicklime 3, Folium Microcoris paniculatae 3.
Above-mentioned raw materials is dried, is ground into thin medicated powder, cross 120 mesh sieves, bottle for subsequent use, powder agent medicine.The using method of medicated powder of the present invention is: dip in the direct external application of upper medicated powder in affected part with absorbent liquor ball, two once.Healing in general about one week.
For proving that the present invention has good curative effect, enumerate model case as follows:
1, all male 3 years old of Cao Yi, outside nostril, take on the back of the body, the erosion of arm many places, diameter 0.3-1 centimetre, has transudate, the course of disease 3 days.Give above-mentioned medicated powder external application, 2 times/day, second day is formed a scab.Decrustation after four days, wound healing.
2, the happy female of Chen Ou 4 years old, patient's arm, ankle, nasal mucosa, lower jaw, shank many places skin ulcer, around blush, has yellow sepage, conscious pruritus, the course of disease 1 week.Give above-mentioned medicated powder external application, second day transudate disappears, and crust starts to be formed, and pruritus alleviates.After one week, crust all comes off, skin healing.
3, the strong man of inscription on pottery 4 years old, patient's corners of the mouth, shank, back many places skin erosion, ooze out, pruritus, around blush, the course of disease 5 days.Give above-mentioned medicated powder external application, second day starts to ooze out obvious minimizing, and aphtha and rotten to the corn face start incrustation, and after 5 days, crust comes off naturally, skin healing.
Claims (2)
1. treat a medicine for pustule ulcer, it is characterized in that: the weight proportion of its each raw material components is: Radix Astragali 28-32, Cortex Phellodendri 28-32, dried Alumen 8-12, chilli seed 18-22, Borneolum Syntheticum 3-7, Rhizoma Coptidis 8-12, Flos Celosiae Cristatae 4-8, Radix Notoginseng 6-10, Flos Papaveris rhoeadis 2-6, Flos Camelliae Japonicae 1-5, Herba Senecionis Scandentis 6-10, Radix Sophorae Tonkinensis 4-8, Fructus Mume 5-7, quicklime 1-5, Folium Microcoris paniculatae 1-5.
2. a kind of medicine for the treatment of pustule ulcer according to claim 1, is characterized in that: the weight proportion of its each raw material components is: the Radix Astragali 30, Cortex Phellodendri 30, dried Alumen 10, chilli seed 20, Borneolum Syntheticum 5, Rhizoma Coptidis 10, Flos Celosiae Cristatae 6, Radix Notoginseng 8, Flos Papaveris rhoeadis 4, Flos Camelliae Japonicae 3, Herba Senecionis Scandentis 8, Radix Sophorae Tonkinensis 6, Fructus Mume 6, quicklime 3, Folium Microcoris paniculatae 3.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210530670.5A CN103110745B (en) | 2012-12-11 | 2012-12-11 | Medicine for treating impetigo |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210530670.5A CN103110745B (en) | 2012-12-11 | 2012-12-11 | Medicine for treating impetigo |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103110745A CN103110745A (en) | 2013-05-22 |
| CN103110745B true CN103110745B (en) | 2015-03-04 |
Family
ID=48409149
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210530670.5A Expired - Fee Related CN103110745B (en) | 2012-12-11 | 2012-12-11 | Medicine for treating impetigo |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103110745B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103110725B (en) * | 2012-12-11 | 2014-07-02 | 余金标 | Medicine for treating herpes simplex |
-
2012
- 2012-12-11 CN CN201210530670.5A patent/CN103110745B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN103110745A (en) | 2013-05-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102657805B (en) | Loquat scented tea and preparation technology thereof | |
| CN101366917B (en) | Traditional Chinese medicine composition for treating chronic pharyngitis | |
| CN104083616A (en) | Buccal tablet for treating chronic pharyngitis | |
| CN103301271B (en) | Tibetan medicine for treating pharyngitis and preparation method thereof | |
| CN103110745B (en) | Medicine for treating impetigo | |
| CN105232957A (en) | Traditional Chinese medicine decoction for treating excess heat syndrome swollen sore throat | |
| CN103202943B (en) | Powder for treating herpes simplex by using abelmosk | |
| CN102274353B (en) | Traditional Chinese preparation for treating ulcers | |
| CN101380431A (en) | Traditional Chinese medicine composition for treating pharyngitis | |
| CN101095824A (en) | Pharynx-cleaning detoxicating capsule | |
| CN102614269A (en) | Method for preparing traditional Tibetan medicine for treating pharyngitis | |
| CN101085069B (en) | Medicine for curing beriberi | |
| CN1480187A (en) | Medication for treating impetigo | |
| CN101700351B (en) | Traditional Chinese medicinal preparation for treating chronic pharyngitis | |
| CN102772682A (en) | Wind-dispelling and heat-clearing tablet | |
| CN103099864A (en) | Pharmaceutical composition for treating pharyngolaryngitis and preparation method thereof | |
| CN103110725B (en) | Medicine for treating herpes simplex | |
| CN103223075B (en) | Traditional Chinese medicinal capsule for treating diphtheria | |
| CN105250534A (en) | Traditional Chinese medicine composition for treating acute and chronic faucitis | |
| CN101797343A (en) | Chinese medicinal formula for treating oral cavity and throat diseases | |
| CN103202970A (en) | Powder for treating pustule sore using Baphicacanthus cusia | |
| CN103933435A (en) | Traditional Chinese medicine preparation for effectively treating dry cough | |
| CN104644756A (en) | Traditional Chinese medicine for treating cold | |
| CN104998103A (en) | Traditional Chinese medicine composition for treating common cold with syndrome of wind-cold fettering the exterior and preparation method thereof | |
| CN105497358A (en) | Asthma treating drug |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CB03 | Change of inventor or designer information |
Inventor after: Wu Xia Inventor after: Xie Qinghuan Inventor after: Xu Baoli Inventor before: Yu Jinbiao |
|
| CB03 | Change of inventor or designer information | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20170823 Address after: 300000 Tianjin City, Hexi District Liheli No. 2 Building 1 102 Co-patentee after: Xie Qinghuan Patentee after: Wu Xia Co-patentee after: Xu Baoli Address before: Chang Huai Wei Zhen Dongfengcun health room 233030 Anhui Longzihu district city of Bengbu Province Patentee before: Yu Jinbiao |
|
| TR01 | Transfer of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150304 Termination date: 20171211 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |